基于病理生理学的中医药综合治疗功能性消化不良研究进展。

IF 4.7 2区 医学 Q1 CHEMISTRY, MEDICINAL
Drug Design, Development and Therapy Pub Date : 2025-06-24 eCollection Date: 2025-01-01 DOI:10.2147/DDDT.S514042
Mingming Fan, Xiangbin Pan, Yingzhe Liu
{"title":"基于病理生理学的中医药综合治疗功能性消化不良研究进展。","authors":"Mingming Fan, Xiangbin Pan, Yingzhe Liu","doi":"10.2147/DDDT.S514042","DOIUrl":null,"url":null,"abstract":"<p><p>Functional dyspepsia (FD) is a common functional gastrointestinal disorder characterized by epigastric pain and symptoms related to meal consumption. According to recent diagnostic criteria, FD can be classified as epigastric pain syndrome (EPS) or postprandial discomfort syndrome (PDS), based on the predominant symptoms. The pathophysiology of FD can be influenced by various factors, including microinflammation, gastrointestinal infections, abnormal gastroduodenal motility, visceral hypersensitivity, disturbances in the brain-gut axis, and psychological factors. As a result, its management requires a comprehensive approach that includes both pharmacological and non-pharmacological interventions such as psychological therapies and adjunctive treatments. However, despite the availability of various treatment options, no contemporary pharmacological agents have been approved specifically for FD. In this context, Traditional Chinese Medicine (TCM) has emerged as a promising alternative that offers notable efficacy and safety in managing FD. Various TCM modalities, including herbal prescriptions, acupuncture, moxibustion, and music therapy have demonstrated therapeutic potential. In this article, we discuss the pathophysiology of FD from a modern medical perspective and describe integrative treatment strategies based on TCM, highlighting the potential benefits of combining the traditional and contemporary approaches.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"19 ","pages":"5349-5367"},"PeriodicalIF":4.7000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205706/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comprehensive Treatment of Functional Dyspepsia Using Traditional Chinese Medicine: A Review Based on Pathophysiological Perspectives.\",\"authors\":\"Mingming Fan, Xiangbin Pan, Yingzhe Liu\",\"doi\":\"10.2147/DDDT.S514042\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Functional dyspepsia (FD) is a common functional gastrointestinal disorder characterized by epigastric pain and symptoms related to meal consumption. According to recent diagnostic criteria, FD can be classified as epigastric pain syndrome (EPS) or postprandial discomfort syndrome (PDS), based on the predominant symptoms. The pathophysiology of FD can be influenced by various factors, including microinflammation, gastrointestinal infections, abnormal gastroduodenal motility, visceral hypersensitivity, disturbances in the brain-gut axis, and psychological factors. As a result, its management requires a comprehensive approach that includes both pharmacological and non-pharmacological interventions such as psychological therapies and adjunctive treatments. However, despite the availability of various treatment options, no contemporary pharmacological agents have been approved specifically for FD. In this context, Traditional Chinese Medicine (TCM) has emerged as a promising alternative that offers notable efficacy and safety in managing FD. Various TCM modalities, including herbal prescriptions, acupuncture, moxibustion, and music therapy have demonstrated therapeutic potential. In this article, we discuss the pathophysiology of FD from a modern medical perspective and describe integrative treatment strategies based on TCM, highlighting the potential benefits of combining the traditional and contemporary approaches.</p>\",\"PeriodicalId\":11290,\"journal\":{\"name\":\"Drug Design, Development and Therapy\",\"volume\":\"19 \",\"pages\":\"5349-5367\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205706/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Design, Development and Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/DDDT.S514042\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S514042","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

功能性消化不良(FD)是一种常见的功能性胃肠疾病,其特征是胃脘痛和与进食有关的症状。根据最近的诊断标准,根据主要症状,FD可分为胃脘痛综合征(EPS)或餐后不适综合征(PDS)。FD的病理生理受多种因素影响,包括微炎症、胃肠道感染、胃十二指肠运动异常、内脏超敏反应、脑肠轴紊乱、心理因素等。因此,其管理需要一种综合的方法,包括药物和非药物干预,如心理治疗和辅助治疗。然而,尽管有各种各样的治疗选择,目前还没有药物被批准专门用于FD。在这种情况下,中医(TCM)已成为一种有希望的替代方法,在治疗FD方面具有显着的有效性和安全性。包括中药处方、针灸、艾灸和音乐疗法在内的各种中医疗法已经显示出治疗潜力。在本文中,我们从现代医学的角度讨论了FD的病理生理,并描述了基于中医的综合治疗策略,强调了传统和现代方法相结合的潜在益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comprehensive Treatment of Functional Dyspepsia Using Traditional Chinese Medicine: A Review Based on Pathophysiological Perspectives.

Functional dyspepsia (FD) is a common functional gastrointestinal disorder characterized by epigastric pain and symptoms related to meal consumption. According to recent diagnostic criteria, FD can be classified as epigastric pain syndrome (EPS) or postprandial discomfort syndrome (PDS), based on the predominant symptoms. The pathophysiology of FD can be influenced by various factors, including microinflammation, gastrointestinal infections, abnormal gastroduodenal motility, visceral hypersensitivity, disturbances in the brain-gut axis, and psychological factors. As a result, its management requires a comprehensive approach that includes both pharmacological and non-pharmacological interventions such as psychological therapies and adjunctive treatments. However, despite the availability of various treatment options, no contemporary pharmacological agents have been approved specifically for FD. In this context, Traditional Chinese Medicine (TCM) has emerged as a promising alternative that offers notable efficacy and safety in managing FD. Various TCM modalities, including herbal prescriptions, acupuncture, moxibustion, and music therapy have demonstrated therapeutic potential. In this article, we discuss the pathophysiology of FD from a modern medical perspective and describe integrative treatment strategies based on TCM, highlighting the potential benefits of combining the traditional and contemporary approaches.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Design, Development and Therapy
Drug Design, Development and Therapy CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
CiteScore
9.00
自引率
0.00%
发文量
382
审稿时长
>12 weeks
期刊介绍: Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: Drug target identification and validation Phenotypic screening and target deconvolution Biochemical analyses of drug targets and their pathways New methods or relevant applications in molecular/drug design and computer-aided drug discovery* Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) Structural or molecular biological studies elucidating molecular recognition processes Fragment-based drug discovery Pharmaceutical/red biotechnology Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) Preclinical development studies Translational animal models Mechanisms of action and signalling pathways Toxicology Gene therapy, cell therapy and immunotherapy Personalized medicine and pharmacogenomics Clinical drug evaluation Patient safety and sustained use of medicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信